Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jaci.2006.06.011 | DOI Listing |
BMC Pediatr
August 2014
Department of Pediatrics, University of Calgary, Foothills Medical Centre, Rm C211, 1403-29TH Street, T2N 2 T9 Calgary, Alberta, Canada.
Background: Little evidence exists regarding the optimal concentration of oxygen to use in the treatment of term neonates with spontaneous pneumothorax (SP). The practice of using high oxygen concentrations to promote "nitrogen washout" still exists at many centers. The aim of this study was to identify the time to clinical resolution of SP in term neonates treated with high oxygen concentrations (HO: FiO2 ≥ 60%), moderate oxygen concentrations (MO: FiO2 < 60%) or room air (RA: FiO2 = 21%).
View Article and Find Full Text PDFPLoS One
December 2010
Department of Physiology, Michigan State University, East Lansing, Michigan, United States of America.
Rationale: Previous in vitro research demonstrated that ascorbate enhances potency and duration of activity of agonists binding to alpha 1 adrenergic and histamine receptors.
Objectives: Extending this work to beta 2 adrenergic systems in vitro and in vivo.
Methods: Ultraviolet spectroscopy was used to study ascorbate binding to adrenergic receptor preparations and peptides.
Eur J Pharmacol
May 2010
Laboratory of Transplantation Immunobiology, Department of Immunology, University of São Paulo, Av. Prof. Lineu Prestes, 1730, ICB IV, 05508-900, São Paulo, SP, Brazil.
Lipopolysaccharides from gram-negative bacteria are amongst the most common causative agents of acute lung injury, which is characterized by an inflammatory response, with cellular infiltration and the release of mediators/cytokines. There is evidence that bradykinin plays a role in lung inflammation in asthma but in other types of lung inflammation its role is less clear. In the present study we evaluated the role of the bradykinin B1 receptor in acute lung injury caused by lipopolysaccharide inhalation and the mechanisms behind bradykinin actions participating in the inflammatory response.
View Article and Find Full Text PDFAAPS PharmSciTech
June 2009
School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Pharmaceutical aerosols have been targeted to the lungs for the treatment of asthma and pulmonary infectious diseases successfully. Micafungin (Astellas Pharma US, Deerfield, IL, USA) has been shown to be an effective antifungal agent when administrated intravenously. Pulmonary delivery of micafungin has not previously been reported.
View Article and Find Full Text PDFJ Allergy Clin Immunol
January 2007
Respiratory Disease Division, Brigham and Women's Hospital, Boston, MA, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!